Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Laser Photonics Reports Full Year Total Net Sales Increase of 144% in Q4 2025 Financial Results (click to learn more) This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Shionogi and Company Ltd (PK) SGIOF

Alternate Symbol(s):  SGIOY

Healthcare Drug Manufacturers - Specialty & Generic
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.

Current News (PINL:SGIOF)

Shionogi to Present New Data at 2018 European Congress of Clinical Microbiology and Infectious Diseases

Business Wire April 18, 2018

Shionogi Announces FDA New Drug Application (NDA) and EMA Marketing Authorization Application (MAA) Acceptances for Lusutrombopag (S-888711)

Business Wire February 26, 2018

Shionogi Announces Positive Top-Line Results For Cefiderocol Pivotal cUTI Clinical Trial

PR Newswire January 12, 2017

Shionogi Submits New Drug Applications In Japan And The U.S. For Naldemedine For The Treatment Of Opioid-Induced Constipation

PR Newswire March 30, 2016
View More News ››

Opinion & Analysis (PINL:SGIOF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:SGIOF)

Possible buy out?

I'm surprised that this company hasn't made an offer to buy Voygeur Pharmaceuticals!  friday night funkin
vicentavines - August 18, 2021

Possible buy out?

I'm surprised that this company hasn't made an offer to buy Voygeur Pharmaceuticals!
Billybub - July 24, 2021
View more Bullboard ››

TomaGold Corp.

TomaGold Corp.

TomaGold Corporation, together with its subsidiaries, engages in the acquisition, exploration, assessment, and development of ...
View More »

Podcasts